MarketInOut Stock Screener Log In | Sign Up

StemCell Institute

TSE • Healthcare • Biotechnology • Quote as of 10/28/2026 15:30
StemCell Institute stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTSE
Market Capitalization7,159.9 mln
Float2.32 mln
Earnings Date05/13/2025

EPS

14.72
Stretched

P / E

48.51
High premium

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.14
Caution advised

Relative Strength

42 / 100
Slightly lagging

Debt / Equity

0.23
Very low leverage

Business Description

Founded in 1999 and based in Tokyo, StemCell Institute Inc. operates across several areas of the healthcare industry in Japan, including storing stem cells, developing new therapies, and managing medical facilities. The company also handles the collection, processing, and sale of biological materials, as well as the transportation and oversight of cell-related services. It operates as part of Trim Medical Holdings Inc.

Key Fundamentals

EPS14.72
P/E48.51
ROE5.51
RPS278
ROIC1.28
ROA1.84
Interest Cover31.59
EBITDA, mln367
EV / EBITDA15.21
EV / EBIT28.01
Revenue, mln2,832
EV / Revenue1.97

Quote Details

Last 716.00
Change 0 (0%)
Open 715.00
Volume 3,800
Turnover 2,720,800
Average Volume 4,609.52

Financial Ratios

Pre-Tax Profit Margin7
Leverage Ratio3.13
Current Ratio1.17
Price / Book2.21
Price / Tangible Book2.37
Debt / Equity0.23
Price / Sales2.56
PEG Ratio1.81

Financial Strength

Altman Z-Score1.62
Piotroski F-Score 4 / 9
Beneish M-Score-2.14
Price to Intrinsic Value2.15
Price to Lynch Fair Value1.87
Price to Graham Number2.28

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.69% 54 / 100   
1 Month -1.78% 58 / 100   
2 Months -4.79% 32 / 100   
6 Months -7.73% 31 / 100   
1 Year -18.54% 14 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog